Key Drivers
- High profitability
- Robust FCF
- Negative equity
AIAI Summary
Reframe MTD as a cash‑rich, margin‑resilient industrial platform whose durable free cash flow and growing services/consumables mix materially de‑risk the long‑term thesis, but near‑term China weakness, lab destocking and tariff noise can cause multi‑quarter margin and valuation volatility that investors must actively manage. Actionable: only add materially on price weakness once you see either clear China/lab stabilization or concrete evidence management is executing tariff offsets and preserving FCF/leverage (monitor quarterly FCF, net debt, and China sales trends).
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •High profitability
- •Robust FCF
- •Negative equity
MTD delivers industry-leading margins and strong free cash flow that support reinvestment and deleveraging, but its negative equity, high leverage and tight liquidity—alongside rich valuation multiples—pose meaningful balance-sheet and valuation risks.
Price Behavior
Key Price Behavior Insights:
- •Short-term downtrend
- •Nearby support
- •Tactical rebound possible
MTD is in a clear short-term downtrend over the last month, sliding about 12.6% from $1377.55 to $1204.48 with immediate support near $1168–$1174 and resistance at $1230–$1250 (major pivot $1375–$1393).
Rapid ~12.6% decline from $1377.55 to $1204.48 over last month signaling weakened momentum
Sentiment & News
Key News Insights:
- •Wide-moat recognition
- •Mixed institutional flows
- •Technical oversold
Mettler-Toledo draws long-term analyst confidence and inclusion on a “wide moat” buy list while institutional flows are mixed and technicals show short-term oversold pressure.
Overall this supports a constructive long-term outlook for MTD amid near-term volatility as some funds trim positions
Similar Companies in Healthcare
Other companies in the same sector with AI ratings